Related Experiment Videos
A scintillation proximity assay for poly(ADP-ribose) polymerase
1Guilford Pharmaceuticals Inc., 6611 Tributary Street, Baltimore, Maryland, 21224, USA.
Analytical Biochemistry
|June 22, 2000
Summary
This study introduces a new scintillation proximity assay (SPA) for Poly(ADP-ribose) polymerase (PARP) detection. This method enables efficient high-throughput screening for novel PARP inhibitors.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Poly(ADP-ribose) polymerase (PARP) is a crucial nuclear enzyme involved in DNA repair.
- PARP activation by DNA damage leads to the synthesis of poly(ADP-ribose) from NAD.
- Current radioactive assays for PARP are hindered by a rate-limiting separation step, impeding large-scale screening for inhibitors.
Purpose of the Study:
- To develop a novel, efficient assay for Poly(ADP-ribose) polymerase (PARP) activity.
- To facilitate high-throughput screening for small-molecule PARP inhibitors.
- To overcome limitations of conventional radioactive PARP enzyme assays.
Main Methods:
- Development of a scintillation proximity assay (SPA) utilizing biotinylated NAD.
- Demonstration of PARP incorporating biotinylated ADP-ribose units into poly(ADP-ribose) polymer.
- Adaptation of the PARP-SPA assay to a 96-well format for automated screening.
Main Results:
- The developed PARP-SPA assay directly measures PARP activity without a separation step.
- Biotinylated NAD allows the synthesized polymer to bind and excite streptavidin-conjugated scintillation beads.
- The assay is suitable for high-throughput screening, enabling efficient identification of PARP inhibitors.
Conclusions:
- The novel PARP-SPA assay offers a streamlined and efficient method for detecting PARP activity.
- This assay is readily adaptable for automated high-throughput screening of potential PARP inhibitors.
- The developed method significantly improves upon conventional assays, facilitating drug discovery efforts.